DVYSR — Devyser Diagnostics AB Share News
0.000.00%
Last trade - 00:00- SEK844.49m
- SEK809.29m
- SEK250.50m
Brief: Devyser Diagnostics Q1 Operating Loss Widens To SEK 19.1 Mln
Brief: Devyser Q1 Adj. EPS at SEK -1.24
Brief: Thermo Fisher Scientific To Commercialize Devyser's Post-Transplant NGS Products
Brief: Devyser Diagnostics Launches First IVDR-Certified Product
Brief: Devyser Q4 Sales SEK 34.2 Million
Brief: Devyser Diagnostics Board Proposes No Dividend For 2022
Brief: Devyser Makes Provisions Due To Retroactive "Payback" Levy
Brief: Devyser Diagnostics Q3 EBIT Loss Widens To SEK 8.2 Mln
Brief: Devyser Establishes Proprietary CLIA Lab, Strengthens Presence On U.S. Market
Brief: Devyser's Quality Management System And Fetal Diagnostics Product Approved Under The New European IVD Regulation
Brief: Devyser Diagnostics Product Approved
Advisory: Inderes rating change alert for Devyser Diagnostics AB withdrawn
Brief: Devyser Diagnostics Q2 EBIT Loss Widens To SEK 12.6 Mln
Brief: Devyser Wins Contract In Canada Worth Just Over SEK 16 Mln
Brief: Devyser Q1 EBIT Swings To Loss SEK 5.2 Million
Brief: Devyser Diagnostics Q4 EBIT Loss Widens To SEK 13.9 Million
Brief: Devyser Acquires Italian SmartSeq
Brief: Devyser Offering Multiple Times Oversubscribed